This combination of activities makes PEDF an exceptional and potent candidate for therapeutic use, and its dual capability to trigger the differentiation of cancer cells and hinder the formation of new blood vessels brings extra therapeutic value in the treatment of various malignancies [8,17]. The gene discussed is SERPINF1; the disease is cancer.